Guo Xiaoyin, Liu Wei, Zhou Kun, Zhu Hui, Pan Lu, Feng Chunping, Liu Ling
Clinical Center for Tumor Therapy, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Department of Rehabilitation Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Front Oncol. 2024 Dec 4;14:1498631. doi: 10.3389/fonc.2024.1498631. eCollection 2024.
Mucinous ovarian cancer (MOC) is characterized by high malignancy, poor prognosis and a high recurrence rate. Surgical adjuvant chemotherapy is the main treatment for MOC. The recurrence rate of advanced mucinous ovarian cancer following surgery is significantly high, with limited efficacious treatment options available. Moreover, chemotherapy alone results in low sensitivity in this context. High-intensity focused ultrasound (HIFU) not only efficiently ablates targeted tumor lesions but also elicits an immune response within the body and increases tumor cell susceptibility to drugs, thus increasing therapeutic effectiveness. We report a case of recurrent mucinous ovarian cancer treated with HIFU combined with chemotherapy, which effectively controlled tumor growth and prolonged patient survival. High-intensity focused ultrasound in combination with chemotherapy for the treatment of recurrent and surgically difficult ovarian cancer could provide new treatment strategies.
黏液性卵巢癌(MOC)具有恶性程度高、预后差和复发率高的特点。手术辅助化疗是MOC的主要治疗方法。晚期黏液性卵巢癌术后复发率显著较高,有效的治疗选择有限。此外,在此情况下单纯化疗敏感性较低。高强度聚焦超声(HIFU)不仅能有效消融靶向肿瘤病灶,还能在体内引发免疫反应,增加肿瘤细胞对药物的敏感性,从而提高治疗效果。我们报告1例采用HIFU联合化疗治疗的复发性黏液性卵巢癌病例,该治疗有效控制了肿瘤生长并延长了患者生存期。高强度聚焦超声联合化疗治疗复发性及手术困难的卵巢癌可为治疗提供新策略。